No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 677,980 | 655,529 | 762,927 | 876,082 | 818,761 | 801,753 | 767,351 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 23,445 | 43,307 | 61,400 | 73,861 | 8,105 | 16,271 | 28,487 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM | 2027E | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Value | ||||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | ||||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | ||||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | ||||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
OMRON Corporation is a global enterprise operating across diverse sectors, including industrial automation, electronic and mechanical components, social infrastructure systems, and healthcare. Its Industrial Automation division offers a comprehensive range of products such as sensors, switches, safety and control devices, relays, advanced automation platforms, motion control systems, robotics, equipment for energy efficiency and environmental management, and power supply solutions. The Electronic and Mechanical Components segment supplies essential items like relays, switches, connectors, sensors, and specialized components for entertainment devices. Through its Social Systems, Solutions and Service Business, OMRON delivers diverse terminal and system solutions, including photovoltaic inverters and battery storage units, advanced railway station equipment (such as automated ticket barriers and vending machines), traffic and road management technology, payment processing systems, and Uninterruptible Power Supply (UPS) units to safeguard against power interruptions. Furthermore, this division provides a spectrum of software development and ongoing maintenance services crucial for supporting societal infrastructure, alongside specialized transport management and infrastructure monitoring systems. Its Healthcare division manufactures a variety of medical and wellness products, including blood pressure monitors, nebulizers, electrotherapy TENS devices, digital thermometers, body composition analyzers, activity trackers, and automated external defibrillators (AEDs), among others. OMRON Corporation has also formed a strategic partnership with JMDC Inc. to collaboratively create personalized solutions aimed at preventing the worsening of conditions and providing care, which involves predicting the risk of specific patient events to support prescription medication regimens and lifestyle adjustments. Tracing its origins back to its founding in Kyoto, Japan, in 1933, the company was initially known as OMRON Tateisi Electronics Co. before officially adopting the name OMRON Corporation in January 1990.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
OMRON Corporation is a global enterprise operating across diverse sectors, including industrial automation, electronic and mechanical components, social infrastructure systems, and healthcare. Its Industrial Automation division offers a comprehensive range of products such as sensors, switches, safety and control devices, relays, advanced automation platforms, motion control systems, robotics, equipment for energy efficiency and environmental management, and power supply solutions. The Electronic and Mechanical Components segment supplies essential items like relays, switches, connectors, sensors, and specialized components for entertainment devices. Through its Social Systems, Solutions and Service Business, OMRON delivers diverse terminal and system solutions, including photovoltaic inverters and battery storage units, advanced railway station equipment (such as automated ticket barriers and vending machines), traffic and road management technology, payment processing systems, and Uninterruptible Power Supply (UPS) units to safeguard against power interruptions. Furthermore, this division provides a spectrum of software development and ongoing maintenance services crucial for supporting societal infrastructure, alongside specialized transport management and infrastructure monitoring systems. Its Healthcare division manufactures a variety of medical and wellness products, including blood pressure monitors, nebulizers, electrotherapy TENS devices, digital thermometers, body composition analyzers, activity trackers, and automated external defibrillators (AEDs), among others. OMRON Corporation has also formed a strategic partnership with JMDC Inc. to collaboratively create personalized solutions aimed at preventing the worsening of conditions and providing care, which involves predicting the risk of specific patient events to support prescription medication regimens and lifestyle adjustments. Tracing its origins back to its founding in Kyoto, Japan, in 1933, the company was initially known as OMRON Tateisi Electronics Co. before officially adopting the name OMRON Corporation in January 1990.